Western blotting further confirmed that the supernatants from ADVNE− or ADVPPE-treated tumor cells activated the TLR4-MyD88-phosphorylated NFκB-NLRP3 (ASC) pathway in BMDMs (Fig. 6F). This evidence concerns the gene MYD88 and neoplasm.